Cigna Faces Lawsuit Over Alleged $12.8 Million Shortfall in Addiction Treatment Payments

The world of addiction treatment is fraught with challenges, not only for patients seeking recovery but also for the providers dedicated to helping them. A recent lawsuit filed by ten California-based addiction treatment providers against Cigna Corporation has brought to light serious allegations regarding underpayments totaling over $12.8 million for services rendered to patients suffering from substance use disorders. This case, filed in August 2026, raises significant questions about the reimbursement practices of health insurance companies, the adequacy of treatment networks, and the legal responsibilities of insurers under federal law.

The central claim is straightforward yet alarming: Cigna allegedly compensated these treatment providers at a meager average of 16.42% of their billed charges, resulting in substantial financial losses for facilities dedicated to providing critical care. This litigation is not just about money; it highlights the broader implications for the addiction treatment landscape and the need for regulatory scrutiny in health insurance practices.

The Allegations Against Cigna

The lawsuit accuses Cigna and its subsidiaries of systematically under-reimbursing out-of-network providers for addiction treatment services. The plaintiffs, representing treatment centers and clinical laboratories, assert that between March 2022 and March 2026, they treated 83 patients but received only a fraction of the amounts they billed. Specifically, they allege that Cigna paid between 0% and 28.29% of the charges, culminating in a total of $2,519,077.43 against aggregate covered charges of $15,338,175.60. This left an outstanding balance of $12,819,098.17, which the providers claim is still owed.

Reimbursement Methodologies Under Scrutiny

The heart of the complaint revolves around Cigna's reimbursement methodologies, known as Maximum Reimbursable Charge (MRC). The plaintiffs argue that Cigna employed two methods—MRC 1 and MRC 2—to determine payment amounts. MRC 1 was supposed to pay the lesser of the provider's normal charge or a percentile of charges based on a database selected by Cigna. MRC 2, described as a 'Medicare-like' rate, was to use a similar methodology that would only apply if Medicare had established rates for the services provided. However, the plaintiffs contend that since Medicare did not have rates for addiction treatment services during the relevant period, the second method was effectively unavailable.

The lawsuit cites Cigna’s own disclaimers, which indicate that in the absence of Medicare rates, payments should have adhered to the MRC 1 methodology. The complaint claims that Cigna, instead, applied a cross-walk coding system to match treatment codes from addiction facilities to those typically used by inpatient psychiatric hospitals and skilled nursing facilities. Such mismatches, the plaintiffs argue, resulted in payments that were drastically lower than what should have been provided.

Questionable Fee Structures and Incentives

In addition to the underpayment allegations, the lawsuit draws attention to Cigna's fee structures and the potential conflicts of interest they create. According to the complaint, Cigna earns two types of fees under its Administrative Services Agreements with self-funded employer-sponsored plans: a per-member monthly fee and a cost containment fee calculated as 27% to 29% of the 'net savings' achieved through lower reimbursements to providers. This structure allegedly incentivizes Cigna to minimize reimbursements, as their earnings increase with the amount they save.

The complaint further alleges that claims were often rerouted to MultiPlan for repricing, which also earned fees based on the reductions achieved. This raises ethical questions about whether Cigna is more motivated to reduce costs than to ensure fair and adequate payments to providers.

Implications for Employers and Patients

This lawsuit has significant implications for employers who sponsor health plans and the patients who rely on these services. Employers should be aware of how their insurance providers manage claims and reimbursements, as discrepancies can lead to inadequate care for employees suffering from addiction. Furthermore, patients may find themselves caught in the middle, facing higher out-of-pocket costs and barriers to accessing necessary treatment as a result of inadequate insurance reimbursements.

Legal Context and Potential Outcomes

The legal landscape surrounding mental health and addiction treatment reimbursement is complex, with statutes like the Mental Health Parity and Addiction Equity Act (MHPAEA) aiming to ensure that mental health services are treated comparably to medical and surgical services. The plaintiffs in this case argue that Cigna's reimbursement practices violate these principles by treating out-of-network substance use disorder providers differently from other healthcare providers.

Additionally, the complaint references a prior settlement involving the U.S. Department of Labor and Cigna, which found that different evidentiary standards were applied to mental health versus medical networks. This history may bolster the plaintiffs' case, as it underscores ongoing issues within Cigna's practices.

Challenges Ahead for the Plaintiffs

While the allegations are serious, it’s important to note that they have not yet been tested in court. Cigna has not filed a response, and the litigation process will likely be lengthy. The plaintiffs' claims span several causes of action, including breach of contract and claims for plan benefits under the Employee Retirement Income Security Act (ERISA). They are seeking compensatory damages, statutory interest, and recovery of cost containment fees, among other forms of relief.

Key Takeaways

• Cigna is alleged to owe $12.8 million to ten addiction treatment providers due to underpayments for services rendered.
• The lawsuit questions Cigna's reimbursement methodologies, particularly the MRC payment structures.
• Concerns have been raised about Cigna's fee structures incentivizing lower payments to providers.
• The case tests the enforcement of the Mental Health Parity and Addiction Equity Act and may affect employer-sponsored health plans.
• The outcome remains uncertain, as the allegations have yet to be adjudicated in court.

Frequently Asked Questions

What is the Maximum Reimbursable Charge (MRC)?

The Maximum Reimbursable Charge (MRC) is a payment methodology used by insurers to determine the amount reimbursed to healthcare providers for services rendered. Under MRC, the insurer pays the lower of the provider's normal charge or a predetermined percentile based on a database of charges for similar services within a geographic area. In this case, the plaintiffs argue that Cigna's application of MRC has resulted in significantly lower payments than warranted.

How does the Mental Health Parity and Addiction Equity Act affect this case?

The Mental Health Parity and Addiction Equity Act (MHPAEA) mandates that mental health and substance use disorder services must be treated comparably to medical and surgical services in health plans. The plaintiffs allege that Cigna's reimbursement practices treat out-of-network substance use disorder providers differently than other providers, which could violate this federal law. The outcome of the lawsuit may set precedent for how these laws are enforced in the future.

What are the potential consequences for Cigna if the plaintiffs win?

If the plaintiffs succeed in their lawsuit, Cigna may be required to pay the outstanding $12.8 million in claims, along with additional damages, attorneys' fees, and potential changes to their reimbursement practices. This may also prompt increased scrutiny on Cigna and other insurers regarding their compliance with federal laws related to mental health and addiction treatment.

How can insured patients affected by this case seek recourse?

Insured patients who believe their claims have been underpaid or mishandled can take several steps. They may contact their insurance provider for clarification on billing and payment practices, file appeals for denied claims, and seek assistance from state insurance regulators. Additionally, patients can advocate for changes in policy by supporting legislative efforts that enhance mental health and addiction treatment coverage.